The FDA detailed its investigation into contamination of sartans with probable carcinogens from certain manufacturing processes.
Hearts could one day be 3D-printed on the International Space Station to ease the donor transplant shortage, according to a company working to develop the technology. Weightlessness means no scaffold is needed. (BBC)
Researchers also developed a new heart-on-a-chip platform with the tissue suspended between two wires made of elastic polymers to help lab-grown heart tissue develop and measure its contractility. (Cell)
An early feasibility study was approved for the Cor Tricuspid ECM cardiac valve intended for treating adults with endocarditis and kids with congenital valve disease, CorMatrix Cardiovascular announced. (Mass Device)
The FDA cleared Imperative Care’s neurovascular access catheters. (Cath Lab Digest)
Medtronic recalled its dual-chamber pacemakers (the Adapta, Versa, Sensia, Relia, Attesta, Sphera, and Vitatron series A, E, G, and Q) due to a glitch in some modes that can cause the device to stop working temporarily. Devices already implanted should be left in an unaffected mode until a software patch is available, the company said. (Star Tribune)
European marketing approval was suspended for the Nellix abdominal aortic aneurysm stent graft system over concerns about suboptimal outcomes when the instructions for use are not followed. (Mass Device)
Zinc deficiency may contribute to uncontrolled high blood pressure, according to a mouse model study in the American Journal of Physiology-Renal Physiology.
A novel sugar-based stent for structural support during difficult microvascular suturing surgeries was promising in preclinical models. (Cardiovascular Business)
A survey of primary care providers suggested low new prescription rates of statins after the 2013 lipid guidelines expanded the statin-eligible population. (Journal of the American Heart Association)
Cachexia is common in the year after ischemic stroke and associated with functional disability, researchers reported at the Heart & Stroke meeting of the European Society of Cardiology and published in the Journal of Cachexia, Sarcopenia and Muscle.